Intervention Protocol

Platinum-induced hearing loss after treatment for childhood cancer

  1. Jorrit W van As1,*,
  2. Henk van den Berg2,
  3. Elvira C van Dalen2

Editorial Group: Cochrane Childhood Cancer Group

Published Online: 14 NOV 2012

DOI: 10.1002/14651858.CD010181

How to Cite

van As JW, van den Berg H, van Dalen EC. Platinum-induced hearing loss after treatment for childhood cancer (Protocol). Cochrane Database of Systematic Reviews 2012, Issue 11. Art. No.: CD010181. DOI: 10.1002/14651858.CD010181.

Author Information

  1. 1

    Emma Children's Hospital / Academic Medical Center, c/o Cochrane Childhood Cancer Group, Amsterdam, Netherlands

  2. 2

    Emma Children's Hospital / Academic Medical Center, Department of Paediatric Oncology, Amsterdam, Netherlands

*Jorrit W van As, c/o Cochrane Childhood Cancer Group, Emma Children's Hospital / Academic Medical Center, PO Box 22660, Amsterdam, 1100 DD, Netherlands. Jorritvas@gmail.com.

Publication History

  1. Publication Status: New
  2. Published Online: 14 NOV 2012

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To evaluate the existing evidence on the association between childhood cancer treatment including platinum analogues and the occurrence of hearing loss.